Compounds > dronabinol
Page last updated: 2024-08-21

dronabinol and Prostatic Neoplasms

dronabinol has been researched along with Prostatic Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gorter, RW1
Cristino, L; De Petrocellis, L; Di Marzo, V; Iappelli, M; Ligresti, A; Orlando, P; Schiano Moriello, A; Stott, CG; Verde, R1
Büchele, B; Gschwend, JE; Kneer, L; Maier, L; Nett, C; Rockemann, M; Schneider, M; Seeling, W; Simmet, T; Steffen, P1
Díaz-Laviada, I; Miguel, A; Ruiz, L1
Díaz-Laviada, I; Ruiz, L; Sánchez, MG; Velasco, L1

Trials

1 trial(s) available for dronabinol and Prostatic Neoplasms

ArticleYear
[Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].
    Der Anaesthesist, 2006, Volume: 55, Issue:4

    Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Arousal; Body Temperature; Double-Blind Method; Dronabinol; Drug Interactions; Hemodynamics; Humans; Lymph Node Excision; Male; Pain Measurement; Pain, Postoperative; Pirinitramide; Prostatectomy; Prostatic Neoplasms; Receptors, Opioid, mu; Respiratory Mechanics

2006

Other Studies

4 other study(ies) available for dronabinol and Prostatic Neoplasms

ArticleYear
[Experiences with dronabinol (delta-tetrahydrocannabinol) in oncological patients with anorexia-cachexia syndrome. Illustration of clinical problems and therapy based on 2 case reports].
    Schmerz (Berlin, Germany), 2004, Volume: 18 Suppl 2

    Topics: Affect; Aged; Analgesics, Non-Narcotic; Anorexia; Bone Neoplasms; Breast Neoplasms; Cachexia; Chronic Pain; Combined Modality Therapy; Dronabinol; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Narcotics; Palliative Care; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Quality of Life

2004
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
    British journal of pharmacology, 2013, Volume: 168, Issue:1

    Topics: Androgen Antagonists; Anilides; Animals; Apoptosis; Cannabidiol; Cannabinoids; Caspase 3; Cell Cycle; Cell Survival; Docetaxel; Down-Regulation; Dronabinol; Drug Interactions; Humans; Male; Mice; Mice, Nude; Nitriles; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Androgen; Taxoids; Tosyl Compounds; Transient Receptor Potential Channels; TRPM Cation Channels; Tumor Cells, Cultured

2013
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
    FEBS letters, 1999, Sep-24, Volume: 458, Issue:3

    Topics: Annexin A5; Apoptosis; Benzoxazines; DNA Fragmentation; Dronabinol; Fluorescent Antibody Technique; Humans; Indoles; Male; Mitochondria; Morpholines; Naphthalenes; Pertussis Toxin; Piperidines; Prostatic Neoplasms; Protein Binding; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Sphingosine; Time Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella

1999
delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.
    European journal of biochemistry, 2001, Volume: 268, Issue:3

    Topics: Dose-Response Relationship, Drug; Dronabinol; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Immunoblotting; Male; Nerve Growth Factor; Pertussis Toxin; Piperidines; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-raf; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella

2001